Current management of incidental gallbladder cancer: A review.
Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, Scanu AM, Porcu A.
Int J Surg. 2022 Feb;98:106234. doi: 10.1016/j.ijsu.2022.106234. Epub 2022 Jan 21.
Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer.
Wang J, Ren M, Yu J, Hu M, Wang X, Ma W, Jiang X, Cui J.
EBioMedicine. 2022 Nov;85:104319. doi: 10.1016/j.ebiom.2022.104319. Epub 2022 Oct 29.
Malignant carcinoid tumor of the gallbladder: a case report and review of literature.
Kumar S, Agarwal S, Bhargava SK, Minocha VR.
Trop Gastroenterol. 1992 Apr-Jun;13(2):78-84.
Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.
Yuan B, Zhao X, Wang X, Liu E, Liu C, Zong Y, Jiang Y, Hou M, Chen Y, Chen L, Zhang Y, Wang H, Fu J.
Clin Transl Med. 2022 Jan;12(1):e678. doi: 10.1002/ctm2.678.
Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing.
Chen P, Wang Y, Li J, Bo X, Wang J, Nan L, Wang C, Ba Q, Liu H, Wang H.
Clin Transl Med. 2021 Jun;11(6):e462. doi: 10.1002/ctm2.462.
Malignant gastrointestinal stromal tumor of the gallbladder.
Park JK, Choi SH, Lee S, Min KO, Yun SS, Jeon HM.
J Korean Med Sci. 2004 Oct;19(5):763-7. doi: 10.3346/jkms.2004.19.5.763.
MicroRNA-195-5p inhibits malignant progression of gallbladder cancer by regulating Wnt3a.
Sun HD.
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7635-7642. doi: 10.26355/eurrev_202112_27610.
Malignant perivascular epithelioid cell tumor of the gallbladder: a case report and review of literature.
Zhao L, Anders KH.
Arch Pathol Lab Med. 2014 Sep;138(9):1238-41. doi: 10.5858/arpa.2013-0092-CR.
Update on immunotherapy in the management of gallbladder cancer.
Kassab J, Saba L, Gebrael G, Kais S, Kassab R, Kourie HR.
Immunotherapy. 2023 Jan;15(1):35-42. doi: 10.2217/imt-2022-0191. Epub 2023 Jan 9.
Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment.
Qin Y, Zhang M, Lei H, Wu H, Huang C, Zhou X, Fu Y, Weng M, Ma M.
Drug Dev Res. 2022 Dec;83(8):1831-1844. doi: 10.1002/ddr.22000. Epub 2022 Oct 2.
